Regenxbio
RGNX
7.56
-0.04
-0.53%
Regenxbio
US · RGNX
#3748 by market cap
Listed 2015
7.56
-0.04
-0.53%
Live - 5344 symbols - heartbeat 353s ago
· 2026-10-08 10:00
Pre-market
7.48
-1.51%
After-hours
7.61
+0.21%
Overnight
7.86
+3.49%
- Market cap
- 498.73M
- P/E (TTM)i
- -2.00
- P/Bi
- 6.95
- EPSi
- -3.76
- Div yieldi
- 0.00%
- 52W posi
- 20%
Reader sentiment
Are you bullish or bearish on RGNX?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 9 analysts
Buy
Avg price target
23.33 +208.8%
Price target rangecurrent 7.56
Low12.00
Avg23.33
High42.00
Buy 89%
Hold 11%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-05 | Mizuho Securities | -- | BUY | 22.00 |
| 2026-09-25 | Stifel | -- | BUY | 42.00 |
| 2026-09-25 | H.C. Wainwright | -- | BUY | 21.00 |
| 2026-09-21 | BofA Securities | -- | BUY | 15.00 |
| 2026-08-26 | H.C. Wainwright | -- | BUY | 21.00 |
| 2026-08-25 | Baird | -- | BUY | 29.00 |
| 2026-08-25 | Clear Street | -- | BUY | 32.00 |
| 2026-08-25 | H.C. Wainwright | -- | BUY | 21.00 |
| 2026-08-24 | BofA Securities | -- | BUY | 15.00 |
| 2026-08-24 | Morgan Stanley | -- | BUY | 18.00 |
| 2026-08-10 | H.C. Wainwright | -- | BUY | 23.00 |
| 2026-08-07 | BofA Securities | -- | BUY | 15.00 |
| 2026-08-07 | Morgan Stanley | -- | BUY | 18.00 |
| 2026-08-07 | Barclays | -- | HOLD | 12.00 |
| 2026-08-06 | RBC Capital | -- | BUY | 19.00 |
| 2026-07-01 | H.C. Wainwright | -- | BUY | 26.00 |
| 2026-06-30 | H.C. Wainwright | -- | BUY | 26.00 |
| 2026-06-25 | Stifel | -- | BUY | 42.00 |
| 2026-06-25 | H.C. Wainwright | -- | BUY | 26.00 |
| 2026-06-24 | Morgan Stanley | -- | BUY | 16.00 |
| 2026-06-24 | H.C. Wainwright | -- | BUY | 26.00 |
| 2026-06-23 | Baird | -- | BUY | 32.00 |
| 2026-06-23 | H.C. Wainwright | -- | BUY | 26.00 |
| 2026-06-22 | H.C. Wainwright | -- | BUY | 26.00 |
| 2026-06-08 | H.C. Wainwright | -- | BUY | 26.00 |
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 0 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: Barclays moved from Buy to Hold on 2026-08-07.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-08-07 | Barclays | BUY → HOLD | 12.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | -- | ±15.17% | +7.43% (in line) |
| 2026/Q1 | 2026-05-14 | -- | ±32.45% | -37.80% (beat) |
| 2025/Q4 | 2026-03-05 | -- | ±38.15% | -4.60% (in line) |
| 2025/Q3 | 2025-11-06 | -- | ±33.09% | -3.79% (in line) |
| 2025/Q2 | 2025-08-07 | -- | -- | -4.01% |
| 2025/Q1 | 2025-05-12 | After close | ±18.59% | +2.63% (in line) |
| 2024/Q4 | 2025-03-13 | After close | ±31.16% | +2.60% (in line) |
| 2024/Q3 | 2024-11-06 | After close | ±21.21% | +18.66% (in line) |
| 2024/Q2 | 2024-08-01 | After close | ±23.48% | -2.03% (in line) |
| 2024/Q1 | 2024-05-08 | After close | ±17.82% | -5.94% (in line) |
| 2023/Q4 | 2024-02-27 | After close | ±17.52% | -0.60% (in line) |
| 2023/Q3 | 2023-11-08 | After close | ±13.10% | +2.44% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 10:00:13 · For reference only, not investment advice and not tailored to your situation.